Clinical Trial Update: A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

This update summarizes a Phase 3 study of NI-071 in rheumatoid arthritis, noting that the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• NI-071

Snippet

Sponsor: Nichi-Iko Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED